These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phase II evaluation of spirogermanium in advanced ovarian carcinoma. Brenner DE; Jones HW; Rosenshein NB; Forastiere A; Dillon M; Grumbine F; Tipping S; Burnett L; Greco FA; Wiernik PH Cancer Treat Rep; 1983 Feb; 67(2):193-4. PubMed ID: 6825131 [No Abstract] [Full Text] [Related]
3. Phase II trial of spirogermanium for treatment of advanced breast cancer. Falkson G; Falkson HC Cancer Treat Rep; 1983 Feb; 67(2):189-90. PubMed ID: 6825129 [No Abstract] [Full Text] [Related]
4. Phase II study of spirogermanium in the treatment of metastatic breast cancer. Pinnamaneni K; Yap HY; Legha SS; Blumenschein GR; Bodey GP Cancer Treat Rep; 1984 Sep; 68(9):1197-8. PubMed ID: 6478457 [No Abstract] [Full Text] [Related]
5. Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial. Kavanagh JJ; Saul PB; Copeland LJ; Gershenson DM; Krakoff IH Cancer Treat Rep; 1985 Jan; 69(1):139-40. PubMed ID: 3967257 [No Abstract] [Full Text] [Related]
6. Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study. Budman DR; Ginsberg S; Perry M; Weinberg V; Schein P; Hanson J; Coleman M; Wood W Cancer Treat Rep; 1982 Aug; 66(8):1667-8. PubMed ID: 7105058 [No Abstract] [Full Text] [Related]
7. Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary. Weiselberg L; Budman DR; Schulman P; Vinciguerra V; Degnan TJ; Pasmantier M Cancer Treat Rep; 1982 Aug; 66(8):1675-6. PubMed ID: 7201885 [No Abstract] [Full Text] [Related]
8. Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study. Schulman P; Davis RB; Rafla S; Green M; Henderson E Cancer Treat Rep; 1984 Oct; 68(10):1305-6. PubMed ID: 6525606 [No Abstract] [Full Text] [Related]
9. Atiprimod: a multi-functional drug candidate for myeloid and other malignancies. Shailubhai K Leuk Res; 2007 Jan; 31(1):9-10. PubMed ID: 16860863 [No Abstract] [Full Text] [Related]
10. Phase I clinical trial of spirogermanium. Schein PS; Slavik M; Smythe T; Hoth D; Smith F; Macdonald JS; Woolley PV Cancer Treat Rep; 1980; 64(10-11):1051-6. PubMed ID: 7459890 [TBL] [Abstract][Full Text] [Related]
11. Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer. Dhingra HM; Umsawasdi T; Chiuten DF; Murphy WK; Holoye PY; Spitzer G; Valdivieso M Cancer Treat Rep; 1986 May; 70(5):673-4. PubMed ID: 3708617 [No Abstract] [Full Text] [Related]
12. [The effectiveness of experimental combined chemical and radiotherapy]. Zedgenidze GA; Amosov IS; Kaperko FF; Kharlampovich SI; Podsosov SP; Tylechkina OD Med Radiol (Mosk); 1967 Apr; 12(4):3-8. PubMed ID: 6052181 [No Abstract] [Full Text] [Related]
13. Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma. Boros L; Tsiatis AA; Neiman RS; Mann RB; Glick JH Cancer Treat Rep; 1986 Jul; 70(7):917-8. PubMed ID: 3719586 [No Abstract] [Full Text] [Related]
14. [The effectiveness of treating dermal reticulosis with prospidin and fotrin]. Mukhamedov N Vestn Dermatol Venerol; 1973 Jan; 47(1):49-52. PubMed ID: 4575610 [No Abstract] [Full Text] [Related]
15. [Clinical evaluation of glyciphosphoramide used alone and in combination with other drugs]. Wang ZY Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):379-81. PubMed ID: 6398774 [No Abstract] [Full Text] [Related]
16. Evolution of chemotherapy with platinum compounds. Walker EM; Walker SM Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825 [TBL] [Abstract][Full Text] [Related]